Detalhe da pesquisa
1.
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Br J Haematol
; 204(4): 1439-1449, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807708